Concomitant infection with COVID-19 and Mycoplasma pneumoniae

por Huang, Allen Chung-Cheng, Huang, Chung-Guei, Yang, Cheng-Ta, Hu, Han-Chung
Publicado 2020

Plasma thrombomodulin levels are associated with acute kidney injury in patients with acute heart failure

por Lin, Shu-Min, Chang, Chih-Hsiang, Lin, Ting-Yu, Huang, Allen Chung-Cheng, Lin, Chiung-Hung, Chen, Yung-Chang, Chu, Pao-Hsien
Publicado 2022

Fluid balance correlates with clinical course of multiple organ dysfunction syndrome and mortality in patients with septic shock

por Huang, Allen Chung-Cheng, Lee, Tim Yu-Ting, Ko, Meng-Cheng, Huang, Chih-Hsien, Wang, Tsai-Yu, Lin, Ting-Yu, Lin, Shu-Min
Publicado 2019

The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma

por Hsu, Ping-Chih, Wang, Chih-Wei, Kuo, Scott Chih-Hsi, Lin, Shu-Min, Lo, Yu-Lun, Huang, Allen Chung-Cheng, Chiu, Li-Chung, Yang, Cheng-Ta
Publicado 2020

Comparison of Clinical Characteristics and Outcomes of Hospitalized Patients Infected with the D614G Strain or Alpha Variant of COVID-19 in Taiwan: A Multi-Center Cohort Study

por Huang, Allen Chung-Cheng, Lin, Shu-Min, Chiu, Tzu-Hsuan, Chang, Ko-Wei, Huang, Tse-Hung, Yang, Tsung-Hsien, Shiao, Yi-Hsien, Lee, Chung-Shu, Chung, Fu-Tsai, Chiu, Cheng-Hsun
Publicado 2022

A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combi...

por Wang, Chin-Chou, Chiu, Li-Chung, Tung, Pi-Hung, Kuo, Scott Chih-Hsi, Chu, Chia-Hsun, Huang, Allen Chung-Cheng, Wang, Chih-Liang, Chen, Chih-Hung, Yang, Cheng-Ta, Hsu, Ping-Chih
Publicado 2021

A retrospective study of alectinib versus ceritinib in patients with advanced non–small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed

por Kuo, Chih-Hsi Scott, Tung, Pi-Hung, Huang, Allen Chung-Cheng, Wang, Chin-Chou, Chang, John Wen-Cheng, Liu, Chien-Ying, Chung, Fu-Tsai, Fang, Yueh-Fu, Guo, Yi-Ke, Yang, Cheng-Ta
Publicado 2021

Clinical and laboratory predictors for disease progression in patients with COVID-19: A multi-center cohort study

por Lin, Shu-Min, Huang, Allen Chung-Cheng, Chiu, Tzu-Hsuan, Chang, Ko-Wei, Huang, Tse-Hung, Yang, Tsung-Hsien, Shiao, Yi-Hsien, Lee, Chung-Shu, Chung, Fu-Tsai, Chen, Chyi-Liang, Chiu, Cheng-Hsun
Publicado 2023

Effects of dexamethasone use on viral clearance among patients with COVID-19: a multicenter cohort study

por Lin, Shu-Min, Lee, Chung-Shu, Huang, Allen Chung-Cheng, Chiu, Tzu-Hsuan, Chang, Ko-Wei, Huang, Tse-Hung, Yang, Tsung-Hsien, Shiao, Yi-Hsien, Chung, Fu-Tsai, Chen, Chyi-Liang, Chiu, Cheng-Hsun
Publicado 2023

The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study

por Hsu, Ping-Chih, Huang, Chun-Yao, Wang, Chin-Chou, Kuo, Scott Chih-Hsi, Chu, Chia-Hsun, Tung, Pi-Hung, Huang, Allen Chung-Cheng, Wang, Chih-Liang, Chiu, Li-Chung, Fang, Yueh-Fu, Yang, Cheng-Ta
Publicado 2020

Front‐line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control

por Huang, Shih‐Hao, Huang, Allen Chung‐Cheng, Wang, Chin‐Chou, Chang, Wen‐Chen, Liu, Chien‐Ying, Pavlidis, Stelios, Ko, Ho‐Wen, Chung, Fu‐Tsai, Hsu, Ping‐Chih, Guo, Yi‐Ke, Kuo, Chih‐Hsi Scott, Yang, Cheng‐Ta
Publicado 2019

Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study...

por Hsu, Ping-Chih, Lee, Suey-Haur, Chiu, Li-Chung, Lee, Chung-Shu, Wu, Chiao-En, Kuo, Scott Chih-Hsi, Ju, Jia-Shiuan, Huang, Allen Chung-Cheng, Li, Shih-Hong, Ko, Ho-Wen, Yang, Cheng-Ta, Wang, Chin-Chou
Publicado 2023

Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosi...

por Hsu, Ping-Chih, Huang, Chun-Yao, Lin, Yu-Ching, Lee, Suey-Haur, Chiu, Li-Chung, Wu, Chiao-En, Kuo, Scott Chih-Hsi, Ju, Jia-Shiuan, Huang, Allen Chung-Cheng, Ko, Ho-Wen, Wang, Chin-Chou, Yang, Cheng-Ta
Publicado 2023

First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer

por Huang, Allen Chung-Cheng, Huang, Chi-Hsien, Ju, Jia-Shiuan, Chiu, Tzu-Hsuan, Tung, Pi-Hung, Wang, Chin-Chou, Liu, Chien-Ying, Chung, Fu-Tsai, Fang, Yueh-Fu, Guo, Yi-Ke, Kuo, Chih-Hsi Scott, Yang, Cheng-Ta
Publicado 2021

Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation

por Kuo, Chih-Hsi Scott, Chiu, Tzu-Hsuan, Tung, Pi-Hung, Huang, Chi-Hsien, Ju, Jia-Shiuan, Huang, Allen Chung-Cheng, Wang, Chin-Chou, Ko, Ho-Wen, Hsu, Ping-Chih, Fang, Yueh-Fu, Guo, Yi-Ke, Yang, Cheng-Ta
Publicado 2022

The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis

por Chiu, Tzu-Hsuan, Tung, Pi-Hung, Huang, Chi-Hsien, Ju, Jia-Shiuan, Huang, Allen Chung-Cheng, Wang, Chin-Chou, Ko, Ho-Wen, Hsu, Ping-Chih, Fang, Yueh-Fu, Guo, Yi-Ke, Kuo, Chih-Hsi Scott, Yang, Cheng-Ta
Publicado 2022

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

por Ju, Jia-Shiuan, Huang, Allen Chung-Cheng, Tung, Pi-Hung, Huang, Chi-Hsien, Chiu, Tzu-Hsuan, Wang, Chin-Chou, Ko, How-Wen, Chung, Fu-Tsai, Hsu, Ping-Chih, Fang, Yueh-Fu, Guo, Yi-Ke, Kuo, Chih-Hsi Scott, Yang, Cheng-Ta
Publicado 2023

Consolidation treatment of durvalumab after chemoradiation in real‐world patients with stage III unresectable non‐small cell lung cancer

por Chu, Chia‐Hsun, Chiu, Tzu‐Hsuan, Wang, Chin‐Chou, Chang, Wen‐Chen, Huang, Allen Chung‐Cheng, Liu, Chien‐Ying, Wang, Chih‐Liang, Ko, Ho‐Wen, Chung, Fu‐Tsai, Hsu, Ping‐Chih, Guo, Yi‐Ke, Kuo, Chih‐Hsi S., Yang, Cheng‐Ta
Publicado 2020

Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clini...

por Lee, Suey-Haur, Lin, Yu-Ching, Chiu, Li-Chung, Ju, Jia-Shiuan, Tung, Pi-Hung, Huang, Allen Chung-Cheng, Li, Shih-Hong, Fang, Yueh-Fu, Chen, Chih-Hung, Kuo, Scott Chih-Hsi, Wang, Chin-Chou, Yang, Cheng-Ta, Hsu, Ping-Chih
Publicado 2022